首页|醒脑静注射液"异病同治"急性脑梗死与急性脑出血作用机制的网络药理学研究

醒脑静注射液"异病同治"急性脑梗死与急性脑出血作用机制的网络药理学研究

扫码查看
目的:采用网络药理学探讨醒脑静注射液"异病同治"急性脑梗死(ACI)与急性脑出血(ACH)的作用机制。方法:利用中药系统药理学数据库及分析平台(TCMSP)与中医药综合数据库(TCMID)获得醒脑静注射液的有效成分及其作用靶点,同时利用人类基因数据库(GeneCards)、在线人类孟德尔遗传数据库(OMIM)、遗传药理学和药物基因组学数据库(PharmGkb)、治疗目标数据库(TTD)和药物靶标数据库(DrugBank)等数据库获取 ACI和 ACH潜在的基因靶点,在 DIAGRAMS平台内绘制共同靶点韦恩图。采用 Cytoscape 3。9软件构建醒脑静注射液"药物-活性成分-潜在靶点"相互作用网络图。利用STRING构建蛋白-蛋白相互作用(PPI)网络并进行拓扑分析。通过 R/BioConductor对共同靶点进行基因本体(GO)及京都基因和基因组百科全书(KEGG)通路富集分析。结果:筛选共得到醒脑静注射液药物活性成分 68种,对应靶点基因 583个,ACI潜在靶点 3 597 个,ACH潜在靶点 3 959 个,三者共同靶点 299个;PPI网络核心蛋白包括血管内皮生成因子 A(VEGFA)、JUN转录因子(JUN)、信号转导与转录激活因子 3(STAT3)、白细胞介素(IL)-6、肿瘤坏死因子(TNF)、清蛋白(ALB)、胱天蛋白酶 3(CASP3)、丝氨酸/苏氨酸蛋白激酶 1(AKT1)、丝裂原活化蛋白激酶(MAPK)3、低氧诱导因子-1α(HIF-1α)、表皮生长因子受体(EGFR)、表皮生长因子(EGF)、前列腺素内过氧化物合酶 2(PTGS2)、IL-1β、基质金属蛋白酶-9(MMP-9)等;其主要生物学通路涉及脂质与动脉粥样硬化、MAPK信号通路、流体剪切应力与动脉粥样硬化、TNF信号通路、凋亡、IL-17 信号通路等。结论:醒脑静注射液通过抗氧化应激、抗炎症反应、抗细胞凋亡和促血管生成等作用机制达到"异病同治"ACI和 ACH的疗效。
Mechanism of"Different Diseases with Same Treatment"with Xingnaojing Injection for the Treatment of Acute Cerebral Infarction and Acute Cerebral Hemorrhage Based on Network Pharmacology
Objective:To explore the mechanism of"different diseases with same treatment"of Xingnaojing injection for treating acute cerebral infarction(ACI)and acute cerebral hemorrhage(ACH)by network pharmacology.Methods:The effective components and the targets of Xingnaojing injection were obtained by Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and Traditional Chinese Medicine Integrated Database(TCMID).The potential gene targets of ACI and ACH were obtained by GeneCards,OMIM,PharmGkb,TTD,and DrugBank.The common target Venn diagram was drawn by DIAGRAMS.The interaction network of"drugs-active ingredients-potential targets"was constructed by Cytoscape 3.9 software.Finally,the protein-protein interaction(PPI)network was constructed by STRING and topology analysis was carried out.Gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment of common targets were analyzed by R/BioConductor.Results:There were 68 active components of Xingnaojing injection,583 corresponding target genes,of which 3 597 potential targets were related to ACI,3 959 potential targets were related to ACH,and there were 299 common targets.PPI network core proteins included vascular endothelial growth factor A(VEGFA),JUN,signal transducers and activators of transcription 3(STAT3),interleukin(IL)-6,tumor necrosis factors(TNF),serum albumin(ALB),caspase-3(CASP3),protein kinase(AKT)1,mitogen activated protein kinase(MAPK)3,hypoxia-inducible factor-1α(HIF-1α),epidermal growth factor receptor(EGFR),epidermal growth factor(EGF),recombinant prostaglandin endoperoxide synthase 2(PTGS2),IL-1β,matrix metalloproteinase 9(MMP-9);mainly pathway involved in lipid and arteriosclerosis,MAPK signal pathway,fluid shear stress and arteriosclerosis,TNF signal pathway,apoptosis,IL-17 signal pathway and so on.Conclusion:Xingnaojing injection achieves the therapeutic effect on ACI and ACH by anti-oxidative stress,anti-inflammatory reaction,anti-apoptosis,and promoting angiogenesis.

acute cerebral infarctionacute cerebral hemorrhageXingnaojing injectionnetwork pharmacologydifferent diseases with same treatment

彭景、陈星、吕秋艺、宋蕾、邹忆怀

展开 >

北京中医药大学东直门医院(北京 100700)

北京中医药大学(北京 100029)

急性脑梗死 急性脑出血 醒脑静注射液 网络药理学 异病同治

国家自然科学基金北京市自然科学基金

819042857182104

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(2)
  • 34